A link between anti-TNFs and increased type I IFN expression has been suggested by previous findings that anti-TNF therapy induces a type I IFN signature in blood of juvenile arthritis patients48 and can exacerbate lupus, a well-known type I IFN-driven autoimmune disease49,50. This evidence concerns the gene TNF and systemic lupus erythematosus.